Projects per year
Personal profile
Chinese Name
Biography
Prof. Yu received his undergraduate education at the Henan University of Traditional Chinese Medicine, and obtained his PhD degree in biochemistry from the Hong Kong University of Science and Technology. Before joining the Hong Kong Baptist University, Prof. Yu once worked at China Pharmaceutical University, Nagasaki University, Hong Kong University of Science and Technology, Xiamen University and University of Macau. Prof. Yu is known for his research in herbal pharmacology, and in processing of Chinese medicinal materials. He has published more than 200 peer-reviewed research papers.
Consun Pharmaceutical Group Limited and Laboratory JaneClare Limited in collaboration with Prof. Yu's team established "Consun Chinese Medicines Research Centre for Renal Diseases" and "JaneClare Transdermal TCM Therapy Laboratory", respectively, in Hong Kong Baptist University.
Prof. Yu serves as Editorial Board Member/Associate Editor/Executive Editor/ Consulting Editor for more than 30 journals, e.g. LiShizhen Medicine and Materia Medica Research, BMC Complementary Medicine and Therapies, Current Topics in Nutraceutical Research, Journal of Alternative, Complementary & Integrative Medicine, Pharmacological Research.
Research Interests
1) Pharmacology of Chinese medicines, focusing on the mechanisms of action of anticancer, anti-inflammation and melanogenesis-modulation herbs; 2) Unique processing of Chinese medicinal herbs, focusing on the mechanisms underlying processing of Chinese medicines, standardization of adjuvant materials for the processing of Chinese medicinal herbs, and quality control of decoction pieces.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Scholars
Collaborations and top research areas from the last five years
-
Pharmacological Studies for Developing Si-Jun-Zi-Tang Extract as an Adjuvant of Temozolomide in Treating Glioblastoma
27/03/24 → 15/10/24
Project: Research project
-
Pharmacological Studies for Developing Si-Jun-Zi-Tang Extract as an Adjuvant of Temozolomide in Treating Glioblastoma
27/03/24 → 15/10/24
Project: Research project
-
靶向DNA复制起始蛋白的共同转录因子PAX2治疗癌症 Targeting PAX2, a common transcriptional regulator of DNA replication-initiation proteins, for treating cancer
YU, Z., FU, X., WANG, L., WANG, X. & WU, J.
1/01/24 → 31/12/26
Project: Research project
-
Pharmacological Studies for Developing Si-Jun-Zi-Tang Extract as an Adjuvant of Temozolomide in Treating Glioblastoma
YU, Z., FU, X., LI, S. M. A., WU, J. & WANG, X.
16/11/23 → 15/05/25
Project: Research project
-
Pharmacological Studies for Using the Rheumatoid Arthritis Drug Kunxian Capsule to Treat IgA Nephropathy
YU, Z. & Xiao, W.
1/07/23 → 30/06/25
Project: Research project
-
A critical review on intestinal mucosal barrier protection effects of dietary polysaccharides
Yan, W., Luo, J., Yu, Z. & Xu, B., Jan 2024, In: Food and Function. 15, 2, p. 481-492 12 p.Research output: Contribution to journal › Review article › peer-review
3 Citations (Scopus) -
Atractylenolide II combined with Interferon-γ synergistically ameliorates colorectal cancer progression in vivo and in vitro by blocking the NF-kB p65/PD-L1 pathway
Wu, Y., Dai, S., Zhang, Y. J., Li, Z., Zhu, B., Liu, Q., Wo, L., Yu, Z., Yuan, X. & Dou, X., 11 Jun 2024, In: Journal of Cancer. 15, 13, p. 4328-4344 17 p.Research output: Contribution to journal › Journal article › peer-review
Open Access -
Geniposide dosage and administration time: Balancing therapeutic benefits and adverse reactions in liver disease treatment
Qiu, J., lin, C., Ren, G., Xu, F., Hu, T., Le, Y., Fan, X., Yu, Z., Liu, Q., Wang, X. & Dou, X., Sept 2024, In: Phytomedicine. 132, 18 p., 155799.Research output: Contribution to journal › Journal article › peer-review
-
Identification of sedative-hypnotic compounds shared by five medicinal Polyporales mushrooms using UPLC-Q-TOF-MS/MS-based untargeted metabolomics
Chen, W., Yu, J. W., Deng, Y. Y., Wong, L. Y., Wang, C., Liang, Y. L., Leung, Y. T., Tian, J. Y., Wu, Y., Leung, K. S. Y., Hu, J., Chen, W. H., Dou, X., Fu, X. Q., Chen, Y. J. & Yu, Z. L., 12 Jan 2024, In: Phytomedicine. 128, 11 p., 155355.Research output: Contribution to journal › Journal article › peer-review
-
Method and apparatus for collecting and quantifying tongue manifestation features
YU, Z. & WANG, Z., 4 Jul 2024, IPC No. A61-ZS-TONG-PT01, 30 Oct 2023, Priority date 29 Dec 2022, Priority No. PCT/CN2023/126008Research output: Patent
Prizes
-
File
-
Certificate for Excellence for an abstract presented at the 2022 World Federation of Chinese Medicine Societies Meeting
FAN, Xiaoyun (Recipient), WU, Ying (Recipient), FU, Xiuqiong (Recipient) & YU, Zhiling (Recipient), 23 Jun 2023
Prize: Award
File
Activities
-
Current Traditional Medicine (Journal)
Zhiling YU (Member of editorial board)
Jan 2024 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Biocell (Journal)
Zhiling YU (Member of editorial board)
10 May 2024 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Journal of Medicine and HealthCare (Journal)
Zhiling YU (Member of editorial board)
16 Apr 2024 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Trends in Immunotherapy (Journal)
Zhiling YU (Editor in chief)
Jan 2024 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Current Research on Complementary and Alternative Medicine (Journal)
Zhiling YU (Member of editorial board)
14 Feb 2024 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)